Dr Joanna J Wykrzykowska (Academic Medical Center, Amsterdam, NL) discusses Updates from the AIDA trial - Comparison of ABSORB BRS with Xience everolimus-eluting metallic stent in routine PCI.
1. Can you remind us of the story of the AIDA clinical study programme to date?
2. How should we interpret the new three-year follow-up data and have we learned anything new?
3. As a result of this data, other registries and RCTs what is needed to restore confidence in the BRS technology, and how can this be achieved?
4. In your opinion, does BRS technology have a future in clinical practice?Interviewer: Liam O'Neill
Videogarpher: Mike Knight Filmed on site at Euro PCR 2019 by Radcliffe Cardiology.